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ABSTRACT
Introduction: Fibromyalgia affects 8% of the population over the age of 40 years, and 75% of the patients with fi bro-
myalgia have poor sleep quality. Objective: To assess the effects of hydrotherapy on the physical function and sleep 
quality of patients with fi bromyalgia. Methods: Patients were under clinical care at the UNASP Outpatient Clinic. This 
study assessed 60 female patients with fi bromyalgia aged between 30 and 65 years. Out of the 60 patients assessed, 
20 were excluded and 10 left the study because they could not comply with the time schedule. All patients completed 
the following questionnaires: Fibromyalgia Impact Questionnaire (FIQ); Pittsburgh Sleep Quality Index, and Epworth 
Sleepiness Scale. Training sessions were performed twice a week for two months, each session lasting 60 minutes. 
Results: Patients’ mean age was 45 years, 66% were active workers, and 34% had quit work. Right after the hydrotherapy 
program, the patients improved the following aspects assessed by use of the FIQ: physical function, work absenteeism, 
ability to do job, pain intensity, fatigue, morning tiredness, stiffness (P < 0.0001), anxiety (P = 0,0013), and depression 
(P < 0.0001). Sleep quality (P < 0.0001) and daytime sleepiness (P = 0.0003) also improved. Conclusion: Hydrotherapy 
improves sleep quality, physical function, professional status, psychological disorders and physical symptoms in patients 
with fi bromyalgia.
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INTRODUCTION
Fibromyalgia syndrome (FMS) is one of the most frequent rheu-
matologic diseases, characterized by diffuse and chronic muscu-
loskeletal pain, with tender points in muscles or in myotendinous 
junctions. There are 18 tender points situated all over the body.1–3
Its etiology is still unknown, and its pathophysiology has 
not been totally understood. However, the following altera-
tions have been evidenced: changes in the metabolism and 
oxygenation of muscle fi bers; an unbalance between pain 
perception and the mechanisms of afferent pathways; and a 
reduction in the serotonin and endorphin levels.4 The pathophy-
siology of FMS is multicausal, and several experiments have 
demonstrated that uncoordinated mechanisms of nociception 
and pain inhibition result from sensory distortion.5
According to Weidebach,6 FMS was not well defi ned before 
the 1970s, when the fi rst fi ndings were published, those that 
determined a more deep research on the disease. Contrary to 
what was thought, it is not an infl ammatory disease, genera-
tes no joint impairment, and causes no deformity. However, 
considering its chronic character, FMS has a negative impact 
on the patients’ quality of life.
In 1990, the American College of Rheumatology (ACR) 
defi ned the following criteria for the classifi cation and diag-
nosis of FMS: 1) frequent complaints of widespread pain 
for at least three months; and 2) presence of diffuse pain, 
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on digital palpation, in at least 11 of the 18 standard tender 
points. Considering that both laboratory and imaging tests of 
infl ammatory activity are normal, the diagnosis of FMS is 
primarily clinical.6,7
Ribeiro and Proietti8 have reported that in addition to pain 
and painful digital palpation of the tender points, patients also 
have nonrefreshed sleep, fatigue, morning stiffness, reduced 
physical functioning, anxiety, and depression, which reduce 
the patients’ ability to perform daily domestic chores. All such 
symptoms make the social and professional life of patients 
with FMS diffi cult.
Approximately 75% of patients with FMS complain of poor 
sleep quality, which is attributed to an electroencephalic disorder, 
the absence of the last stage of sleep, called rapid eye movement 
(REM) sleep.9 According to Dinges et al.,10 daytime sleepiness is 
one of the most frequent alterations of patients with FMS. Ferro 
et al.11 have shown the relationship between poor quality of sleep 
and higher predisposition to other diseases. Affl eck et al.12 have 
shown the relationship between pain and sleep in patients with 
FMS, and have concluded that one of the major complaints is 
sleep deprivation related to widespread pain. Martinez et al.13 
have shown the relationship between the number of tender points 
and loss of physical function, and that patients with FMS are at 
a disadvantage as compared to healthy individuals. 
Hydrotherapy, usually performed in warm water (32ºC–33ºC), 
is strongly indicated for the treatment of FMS. During immer-
sion, sensory stimuli compete with painful stimuli, interrupting 
the pain pathway.14 The effects of hydrotherapy are related to 
pain relief, a reduction in spasms, muscle relaxation, an incre-
ase in the range of motion, an increase in blood circulation, 
muscle strengthening, an increase in muscle resistance, and 
improvement in self-esteem.15
The present study aimed at assessing the improvement provi-
ded by hydrotherapy to patients with FMS regarding the following 
aspects: pain; sleep irregularities; muscle fatigue; depression; 
anxiety; and their reduced ability to perform daily activities.
METHODS
This is a self-controlled prospective study assessing 60 female 
patients clinically diagnosed with FMS according to ACR criteria 
(frequent complaints of widespread pain for at least three months 
and diffuse pain, on digital palpation, in at least 11 of the 18 stan-
dard tender points). Of the 60 female patients assessed, 20 did 
not meet the inclusion criteria and 10 left the study because they 
could not abide by the time schedule. Thus, this study included 
30 female patients aged 35–65 years, who had cognitive capacity 
to understand the purposes of the study and to sign the written 
informed consent, regardless of marital status, race, religion, and 
socioeconomic aspects. The following patients were excluded 
from the study: those already practicing bodybuilding and other 
physical activities at the gym before beginning the hydrotherapy 
program; and those who had any dermatologic disease, any car-
diorespiratory change incompatible with the practice of aerobic 
exercises, and any severe comorbidity.
In this study, the hydrotherapy program was conducted in 
an indoor warm pool (32ºC) at the hydrotherapy sector of the 
Policlínica do Centro Universitário Adventista de São Paulo 
(UNASP). Data were collected only after approval by the 
institutional Ethics Committee.
All patients were assessed before and immediately after the 
intervention by the same observer, by using a form with demo-
graphic and clinical data. To assess the patients’ quality of life, 
the Fibromyalgia Impact Questionnaire (FIQ) was used. It is an 
instrument to specifi cally assess the quality of life of patients 
with FMS, comprising 19 questions related to physical function, 
professional status, general well-being, psychological disorders 
(such as anxiety and depression), and physical symptoms (such 
as pain, sleep, fatigue, and stiffness), and organized into 10 items. 
The higher score, the greater the impact of FMS on the patient’s 
quality of life. Burckhardt et al.16 have concluded that the FIQ 
is valid to be used in clinical and research situations.
To assess sleep quality, the Pittsburgh Sleep Quality Index 
(PSQI), whose reliability and validity had been previously 
established, was used. That questionnaire comprises 19 items, 
grouped into seven components, and each of the seven compo-
nents has a maximum possible score of 3. Those components 
are as follows: 1) subjective sleep quality; 2) sleep latency; 
3) sleep duration; 4) habitual sleep effi ciency; 5) sleep distur-
bance; 6) use of sleeping medication; and 7) daytime dysfunc-
tion. The scores of the seven components are added together 
to obtain the global score of the PSQI, which ranges from 0 to 
21. Scores of 0–4 indicate good sleep quality; of 5–10, poor 
quality; and over 10, sleep disorder.17
The Epworth Sleepiness Scale (ESS) was applied to assess 
and quantify daytime sleepiness during eight daily activities. 
The score obtained from the answers ranges from 0 to 24, 10 
being the cutoff point for normality.18
The intervention protocol was applied twice a week, and 
comprised 15 group sessions of 60 minutes each, spent entirely 
in the water, respecting individual limits and each patient’s 
progress. Arterial blood pressure was measured before every 
hydrotherapy session. Every therapeutic session comprised four 
phases: 1) warm-up obtained with straight line walking along 
the pool extension, in forward, backward and lateral stepping 
(for 5 minutes); 2) muscle stretching for upper and lower limbs 
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and back (for 15 minutes – all stretching positions were held for 
20 seconds and performed consecutively twice); 3) free active 
exercises for upper and lower limbs, initially non-weight bear-
ing exercises, progressing to exercises with fl oatation devices 
and aquatic weights ranging from 0.5 kg–1 kg (for 30 minutes 
– trainings were performed as three sets of 12 repetitions); and 4) 
relaxation with active stretching for upper and lower limbs and 
posterior and anterior back muscles, associated with respiratory 
exercises, promoting progressive relaxation (for 10 minutes).
Statistical analysis
Data are expressed as means and standard deviations. 
Kolmogorov-Smirnov test was used to analyze data normality. 
Student t test was used to analyze pre- and post-intervention 
data. The statistical signifi cance level adopted was P < 0.05. 
The sample size was calculated based on the outcome variable 
sleep quality, by use of the equation: expected effect/standard 
deviation (E/S). In this study, the expected effect was chosen as 
a 4-point decrease between pre- and post-intervention (minimal 
important clinical difference), and the standard deviation of 
the sample considered was the variability in the PSQI score. 
Thus, for an α = 0.05 and a statistical power of β = 0.8, 27 
patients were necessary for sample power. All patients, even 
those participating in only one exercise session, were assessed 
by use of the intention-to-treat method.
RESULTS
This study included 30 female patients with FMS aged 35 to 65 
years (mean age, 50.8 ± 12.5 years). Of those patients, 34.14% 
were professionally active, and 24.39% were on a leave of 
absence due to medical reasons. The mean number of tender 
points was 14.8 ± 3.1. Table 1 shows their other characteristics.
Regarding the impact of FMS on the patients’ lives, they 
initially showed altered physical function, high work absen-
teeism rate, reduced ability to do job, severe pain, fatigue, 
morning tiredness, stiffness, and depression.
Immediately after the hydrotherapy program, those do-
mains signifi cantly improved (P < 0.0001). Anxiety signifi -
cantly improved (P = 0.0013), but general well-being did not 
signifi cantly improve (P = 0.05) (Table 2). 
Regarding sleep, which was initially disturbed, a signifi cant 
improvement was observed immediately after the hydrotherapy 
program (the score passed from 39.5 ± 6.29 to 33.2 ± 6.60; 
P < 0.0001) (Figure 1). Similarly, the sleep quality, initially altered, 
improved after the hydrotherapy program, with sleepiness intensi-
ty passing from 13.8 ± 7.28 to 10.1 ± 7.36; P = 0.0003 (Figure 2).
The impact of FMS did not correlated positively with sleep 
quality. However, the patients more affected by FMS reported 
worsening of their sleep quality (r = 0.54; P = 0.0039) (Figure 3).
Pain intensity correlated positively with sleepiness. 
However, the patients more affected by FMS reported increased 
sleepiness (r = 0.049; P = 0.0024) (Figure 4). 
Table 1 
Characteristics of the patients with fi bromyalgia
Mean Standard deviation
Age 51 12.562
Weight 70.63 13.43
Height 1.56 7.450
Associated co-morbidities 4
Disease duration 4.36 3.200
Tender points 14.89 3.107
Table 2 
Assessment of the impact of fi bromyalgia before and   
after the hydrotherapy program
Domains Before After P
Physical function 13.5 ± 5.7 9.4 ± 3.6 < 0.0001
Well-being 2.7 ± 1.7 3.9 ± 2.0 > 0.05
Work absenteeism 5.7 ± 2.9 1.6 ± 1.7 < 0.0001
Ability to do job 9.3 ± 1.9 6 ± 2.8 < 0.0001
Pain intensity 9.7 ± 0.8 5.8 ± 2.9 < 0.0001
Fatigue 9.6 ± 0.9 5.9 ± 3.0 < 0.0001
Morning tiredness 9.2 ± 1.9 6.2 ± 2.5 < 0.0001
Stiffness 9.5 ± 1.2 6.2 ± 3.4 < 0.0001
Anxiety 9.2 ± 1.6 6.5 ± 3.1 0.0013
Depression 9.2 ± 1.6 4.8 ± 3.2 < 0.0001
Figure 1
Sleep quality assessed before and after the hydrotherapy 
program. 
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DISCUSSION
The original fi nding of this study was that hydrotherapy proved 
effective to improve the sleep quality and the physical function 
of patients with fi bromyalgia after 15 sessions.
FMS is believed to have changes in the musculoskeletal, 
neuroendocrine, and central nervous systems. Because muscle 
pain is the major symptom of FMS, the primary cause of the 
syndrome was believed to be found in the musculoskeletal 
system. From the histological viewpoint, abnormalities in the 
muscular structure of patients with FMS, such as atrophic fi bers 
and presence of elastic or reticular fi bers that are not seen in 
the normal muscular tissue, were identifi ed. It is worth noting 
the presence of functional changes, such as a reduction in high-
energy phosphate concentration and in muscle oxygenation, 
and impaired blood fl ow.19 Such changes are similar to those 
of non-physically-fi t individuals with no disease. That is why 
those studies have not progressed. 
Medicamentous therapy alone has proved not to be enough 
to treat the disease, and, thus, studies on alternative resources 
to reduce pain are required. Based on studies recommending 
physical therapy in the treatment of FMS, this study assessed 
the use of a pre-established program of water exercises to ap-
proach that syndrome.
The physiological effects of hydrotherapy originate from 
the combination of the physical effects of water (thermal/me-
chanical) and the effects of exercise.11 In fact, in the therapeutic 
pool, physical activities can be more easily performed due to 
fl otation and a reduction in the gravitational force. This results 
in a less painful and easier practice of exercises as compared 
to that on the ground. Thus, in addition to muscle relaxation 
due to warm water, hydrotherapy provides enhancement 
in self-confi dence and faster improvement of patients with 
fi bromyalgia.20
The FIQ is an instrument that has been used in several 
clinical studies to assess physical function and the impact of 
fi bromyalgia on patients’ quality of life.21 It assesses quality 
of life specifi cally in patients with FMS, along with questions 
relate d to physical function, professional status, psychological 
disorders, and physical symptoms. Its Portuguese version was 
validated in 2006,22 and proved to be an instrument of easy 
understanding and applicability, valid and reliable to measure 
the physical function and the health status of patients with 
FMS, helping with its diagnosis and treatment.
This study confi rms the fi ndings about alterations in sleep 
quality and its improvement achieved after a hydrotherapy 
program. Studies have shown that nonrestorative sleep is 
present in 76%−90% of the patients with FMS, as compared to 
Figure 2
Sleepiness intensity assessed before and after the hydro-
therapy program.
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Figure 3
Correlation between sleep quality and impact of fi bromyalgia.
Figure 4
Correlation between sleep quality and pain intensity.
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10%−30% of healthy individuals.23 Poor sleep quality has been 
reported by 99% of the participants in the study by Theadom 
et al.,24 that assessed 101 patients diagnosed with FMS and 
evaluated by PSQI. Sleep quality was signifi cantly predictive 
of pain, fatigue, and social functioning in patients with FMS. 
Sleep quality is hard to defi ne and measure, because of sleep 
complexity and variability among individuals. It comprises 
quantitative aspects, such as the number of night awakenings, 
sleep duration, and latency, and other aspects, such as sleep 
depth, tranquility, and rest sensation after sleep.25
In the present study, the instrument used to measure sub-
jective sleep quality was the PSQI, whose Portuguese version 
was validated in 2008 by Bertolazi.26 It provides an index of 
severity and nature of the sleep disorder in the past month, be-
ing a safe, reliable, and non-invasive method, easy to apply.26 
Before intervention, frequent night awakenings and few hours 
of actual sleep yielded a mean score of 39.5. After intervention, 
approximately 80% of the patients reported an improvement 
in their sleep quality, with a mean score reduction to 33. Such 
fi ndings led us to state that hydrotherapy aids in improving 
sleep disorders, and, consequently, sleep quality.
The other instrument used was ESS, developed in 1991 by 
Dr. John W. Murray to measure excessive daytime sleepiness.27 
According to the author, similarly to any other questionnaire, 
the measuring is not subjective, although it depends on the 
patient’s reading ability, understanding, and honest answer.28 
In this study, the patients reported excessive sleepiness dur-
ing daily activities before intervention, their mean ESS score 
being 13.88. This excessive sleepiness can be associated with 
frequent night awakenings, which alter the sleep/wakefulness 
cycle. Those alterations in the sleep pattern can result in tired-
ness and fatigue. After intervention, their mean ESS score was 
10, showing a signifi cant improvement. In a study with 30 
individuals with FMS and using the ESS, daytime sleepiness 
was associated with a higher severity of FMS and more marked 
changes in polysomnography.29
The improvement in hypersomnolence and in sleep quality 
can be related to an increase in serotonin levels, resulting from 
the aerobic exercises performed in water at 32ºC. According 
to Goldenberg et al.,30 patients with FMS have a reduction in 
serotonin levels, which alters their sleep. However, increased 
serotonin levels lead to increased melatonin production, which 
regulates sleep and improves its quality, providing the rest 
sensation.
In this study, patients with FMS showed a reduction in physi-
cal function. According to Chaitow et al.,31 patients with FMS 
have physically unfi t muscles, tendency towards muscle micro-
traumas, pain, and chronic fatigue. The improvement in their 
physical function relates to the aerobic exercises performed in 
water, affecting mainly the cardiovascular and musculoskeletal 
systems, providing the following: an increase in cardiac output;32 
rightward shift of the hemoglobin curve, increased muscle cap-
illarity, and reduced resistance to O2 diffusion from red blood 
cells to contractile muscle fi bers;33 and remodeling of exercised 
muscles, with a change of  type II B fi bers into type II A fi bers, 
and an increase in the number, size and enzyme concentration 
of mitochondria in slow-contraction muscle cells.34
One limitation of this study was not performing polysom-
nography, which is the gold-standard test to assess sleep quality. 
However, the results of this study are not invalid, considering 
the reliability of its method.
CONCLUSION
Hydrotherapy is well indicated to patients with fi bromyalgia, 
improving their sleep quality, physical function, professional 
status, psychological disorders and physical symptoms. 
Assessing the quality of life before and after the interven-
tion showed an improvement in the patients’ subjective per-
ception of their physical and psychological conditions. Thus, 
interventions to improve sleep quality and physical function 
can contribute to improve the health and quality of life of 
patients with FMS.
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